Your browser doesn't support javascript.
loading
Imatinib Mesylate.
Waller, Cornelius F.
Affiliation
  • Waller CF; Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Centre Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. cornelius.waller@uniklinik-freiburg.de.
Recent Results Cancer Res ; 212: 1-27, 2018.
Article in En | MEDLINE | ID: mdl-30069623
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gastrointestinal Stromal Tumors / Protein Kinase Inhibitors / Imatinib Mesylate / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Recent Results Cancer Res Year: 2018 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gastrointestinal Stromal Tumors / Protein Kinase Inhibitors / Imatinib Mesylate / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Recent Results Cancer Res Year: 2018 Type: Article Affiliation country: Germany